Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Life After Woodcock: US FDA Drug Center’s Leadership Transition
Jun 01 2020
•
By
Michael McCaughan
COVID-19 initiatives mark the third time Woodcock has moved up into the commissioner’s office since she first became CDER director in 1994.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Agency Leadership